Skip to main content

Table 4 Comparison of blood parameters between two groups postoperative

From: A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume

 

Total

Restenosis

No restenosis

P value

Erythrocytic,× 1012/L

4.51 ± 0.57

4.39 ± 0.52

4.54 ± 0.59

0.16

Hemoglobin, g/L

141.3 ± 13.4

141.17 ± 14.5

141.38 ± 13.24

0.93

Leukocyte,× 109/L

8.43 ± 2.86

8.46 ± 2.23

8.42 ± 3.00

0.93

Neutrophil,× 109/L

5.90 ± 2.69

5.83 ± 1.74

5.92 ± 2.88

0.80

Neutrophil ratio,%

68.73 ± 9.03

68.47 ± 8.37

68.80 ± 9.21

0.85

Lymphocyte,%

1.65 ± 0.60

1.71 ± 0.57

1.63 ± 0.61

0.52

Lymphocyte ratio,%

20.67 ± 6.88

20.77 ± 6.48

20.64 ± 7.00

0.92

NLR

9.88 ± 0.42

10.16 ± 0.88

9.81 ± 0.47

0.72

Eosinophil,× 109/L

0.21 ± 0.17

0.21 ± 0.16

0.21 ± 0.18

0.98

Eosinophil ratio,%

2.48 ± 1.76

2.52 ± 1.86

2.47 ± 1.47

0.87

Basophils,× 109/L

0.04 ± 0.05

0.03 ± 0.03

0.04 ± 0.05

0.24

Basophils ration,%

0.47 ± 0.42

0.40 ± 0.16

0.48 ± 0.47

0.30

PDW,%

17.41 ± 3.05

17.37 ± 1.04

17.42 ± 3.37

0.93

Platelet,× 109/L

216.5 ± 81.3

168.2 ± 43.65

228.4 ± 84.06

0.001

MPV,fL

9.28 ± 0.78

10.04 ± 0.68

9.11 ± 0.79

< 0.001

PCD,× 109/L

− 14.79 ± 54.16

−36.08 ± 46.23

−5.59 ± 54.82

0.01

MPVD, fL

0.90 ± 0.94

1.58 ± 1.07

0.75 ± 0.87

< 0.001

MPVDR,%

6.41 ± 12.19

19.24 ± 11.45

10.47 ± 11.92

< 0.001

MPVD ≥1.5 fL

48 (27.7)

22 (64.7)

26 (18.7)

< 0.001

MPVDR ≥17.9%

49 (28.3)

21 (61.8)

26 (20.1)

< 0.001

  1. Key: PDW platelet distribution width, MPV mean platelet volume, PCD platelet count difference, MPVD mean platelet volume difference, MPVDR mean platelet volume difference ratio, NLR neutrophil–lymphocyte ratio